European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

A patient with angina at night

Clinical case

Authors:

Frank A. Flachskampf - Uppsala Universitet, Akademiska Sjukhuset, Uppsala, Sweden
Roger R.J.C. Hall - University of East Anglia, Norwich, United Kingdom

Educational Resource:

ESC Core Curriculum Chapter 3 (Non-invasive imaging), Chapter 9 (Chronic Ischaemic Heart Disease)

Introduction:

A 66 year old male patient was referred for evaluation. He had suffered from several nightly anginal attacks but had been symptom-free for the last days.His resting ECG is reproduced in Fig.1. A bicycle exercise ECG test showed no further abnormalities and did not elicit anginal symptoms. He was a former smoker and had hypertension, hypercholesterolemia, and an untreated, subclinical type 2 diabetes. The patient had recently undergone computed tomography with the result of an elevated Agatston calcification score of 172 (between 50th and 75th percentile of age related average).

 
Question 1
How would you continue evaluation in this patient?
   
 





 

Question 2
How would you proceed further?
   
 





 

Question 3
How would you further treat the patient?
   
 



 

Conclusion

The case illustrates the functional benefit of revascularization of the posterolateral branch of the circumflex artery in this case of a patient with nightly angina. The findings indicate retrospectively that there was viable, but non-contracting (hibernating) myocardium in the perfusion territory of the posterolateral branch, which recovered contractile function after revascularization. Whether this treatment improves overall prognosis, is still a matter of debate. However, there are meta-analytic data suggesting a clear survival benefit of revascularization in the presence of viable, non-contracting (hibernating) myocardium [4], while the recent STICH trial did not show a clear benefit [5] .

References

[1] Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG).
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81

[2] Underwood SR, Bax JJ, vom Dahl J, Henein MY, van Rossum AC, Schwarz ER, Vanoverschelde JL, van der Wall EE, Wijns W; Study Group of the European Society of Cardiology. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 2004;25:815-36

[3] European Association for Percutaneous Cardiovascular Interventions, Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P; EACTS Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Kearney P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M.
Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010 Oct;31(20):2501-55

[4] Allman KC, Shaw LJ, Hachamovitch R, Udelson JE.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.
J Am Coll Cardiol 2002;39:1151-8

[5] Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza JA; STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364(17):1617-25